The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 22, 2024
Filed:
May. 10, 2022
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
Gregg Timony, Carlsbad, CA (US);
Sheila Gujrathi, Rancho Santa Fe, CA (US);
Robert Peach, San Diego, CA (US);
Allan Olson, San Diego, CA (US);
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 31/436 (2006.01); A61K 31/519 (2006.01); A61K 31/58 (2006.01); A61K 38/13 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 1/00 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 31/436 (2013.01); A61K 31/519 (2013.01); A61K 31/58 (2013.01); A61K 38/13 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 37/06 (2018.01); C07K 2317/56 (2013.01);
Abstract
The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.